Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma

Abstract Aim Although inflammation‐based markers in cancer have been used for prognostic prediction, the most useful marker for hepatocellular carcinoma (HCC) has not been established. We investigated the usefulness of various inflammation‐based markers in HCC patients after hepatectomy. Methods A t...

Full description

Bibliographic Details
Main Authors: Masateru Yamamoto, Tsuyoshi Kobayashi, Shintaro Kuroda, Michinori Hamaoka, Sho Okimoto, Naruhiko Honmyo, Megumi Yamaguchi, Hideki Ohdan
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Annals of Gastroenterological Surgery
Subjects:
Online Access:https://doi.org/10.1002/ags3.12286
id doaj-b46aa1ef547d4309b24d16151f4f3649
record_format Article
spelling doaj-b46aa1ef547d4309b24d16151f4f36492021-05-02T12:22:09ZengWileyAnnals of Gastroenterological Surgery2475-03282019-11-013666767510.1002/ags3.12286Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinomaMasateru Yamamoto0Tsuyoshi Kobayashi1Shintaro Kuroda2Michinori Hamaoka3Sho Okimoto4Naruhiko Honmyo5Megumi Yamaguchi6Hideki Ohdan7Department of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanAbstract Aim Although inflammation‐based markers in cancer have been used for prognostic prediction, the most useful marker for hepatocellular carcinoma (HCC) has not been established. We investigated the usefulness of various inflammation‐based markers in HCC patients after hepatectomy. Methods A total of 478 patients who underwent initial hepatectomy for HCC from 2009 to 2015 and were diagnosed with pathological HCC were included in this retrospective study. Inflammation‐based markers consisted of the C‐reactive protein to albumin ratio (CAR), Glasgow prognostic score (GPS), neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio, platelet to lymphocyte ratio and prognostic index. Univariate and multivariate analyses for overall survival (OS) and disease‐free survival (DFS) using the Cox proportional hazard model were carried out. Kaplan‐Meier analysis and log‐rank test were used for comparison of OS and DFS. To reduce influences of selection bias and confounders for stratifying CAR, clinicopathological characteristics of patients were balanced by propensity score matching. Results Multivariate analysis identified only high CAR (>0.027) as an indicator of poor OS, and high CAR and high GPS (1‐2) as indicators of poor DFS among inflammation‐based markers. After propensity score matching, 124 patients each with low CAR and high CAR were matched. High CAR was correlated with both poor OS and DFS. Conclusion C‐reactive protein to albumin ratio was the most valuable prognostic indicator after hepatectomy for HCC among inflammation‐based markers.https://doi.org/10.1002/ags3.12286C‐reactive protein to albumin ratioGlasgow prognostic scorehepatocellular carcinomalymphocyte to monocyte rationeutrophil to lymphocyte ratio
collection DOAJ
language English
format Article
sources DOAJ
author Masateru Yamamoto
Tsuyoshi Kobayashi
Shintaro Kuroda
Michinori Hamaoka
Sho Okimoto
Naruhiko Honmyo
Megumi Yamaguchi
Hideki Ohdan
spellingShingle Masateru Yamamoto
Tsuyoshi Kobayashi
Shintaro Kuroda
Michinori Hamaoka
Sho Okimoto
Naruhiko Honmyo
Megumi Yamaguchi
Hideki Ohdan
Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
Annals of Gastroenterological Surgery
C‐reactive protein to albumin ratio
Glasgow prognostic score
hepatocellular carcinoma
lymphocyte to monocyte ratio
neutrophil to lymphocyte ratio
author_facet Masateru Yamamoto
Tsuyoshi Kobayashi
Shintaro Kuroda
Michinori Hamaoka
Sho Okimoto
Naruhiko Honmyo
Megumi Yamaguchi
Hideki Ohdan
author_sort Masateru Yamamoto
title Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
title_short Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
title_full Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
title_fullStr Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
title_full_unstemmed Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
title_sort verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
publisher Wiley
series Annals of Gastroenterological Surgery
issn 2475-0328
publishDate 2019-11-01
description Abstract Aim Although inflammation‐based markers in cancer have been used for prognostic prediction, the most useful marker for hepatocellular carcinoma (HCC) has not been established. We investigated the usefulness of various inflammation‐based markers in HCC patients after hepatectomy. Methods A total of 478 patients who underwent initial hepatectomy for HCC from 2009 to 2015 and were diagnosed with pathological HCC were included in this retrospective study. Inflammation‐based markers consisted of the C‐reactive protein to albumin ratio (CAR), Glasgow prognostic score (GPS), neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio, platelet to lymphocyte ratio and prognostic index. Univariate and multivariate analyses for overall survival (OS) and disease‐free survival (DFS) using the Cox proportional hazard model were carried out. Kaplan‐Meier analysis and log‐rank test were used for comparison of OS and DFS. To reduce influences of selection bias and confounders for stratifying CAR, clinicopathological characteristics of patients were balanced by propensity score matching. Results Multivariate analysis identified only high CAR (>0.027) as an indicator of poor OS, and high CAR and high GPS (1‐2) as indicators of poor DFS among inflammation‐based markers. After propensity score matching, 124 patients each with low CAR and high CAR were matched. High CAR was correlated with both poor OS and DFS. Conclusion C‐reactive protein to albumin ratio was the most valuable prognostic indicator after hepatectomy for HCC among inflammation‐based markers.
topic C‐reactive protein to albumin ratio
Glasgow prognostic score
hepatocellular carcinoma
lymphocyte to monocyte ratio
neutrophil to lymphocyte ratio
url https://doi.org/10.1002/ags3.12286
work_keys_str_mv AT masateruyamamoto verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma
AT tsuyoshikobayashi verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma
AT shintarokuroda verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma
AT michinorihamaoka verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma
AT shookimoto verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma
AT naruhikohonmyo verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma
AT megumiyamaguchi verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma
AT hidekiohdan verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma
_version_ 1721491545205506048